Publications

Journal Article Review Epublish 7 citations

PubMed: 37959232 DOI: 10.3390/jcm12216767

Oocyte Cryopreservation in Women with Ovarian Endometriosis.

J Clin Med 12(21)

Authors: Judith-Marie Mifsud, Livia Pellegrini, Mauro Cozzolino

Affiliations

  • IVIRMA Global Research Alliance, IVIRMA Roma, 00169 Rome, Italy.
  • IVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.

Abstract

Ovarian endometriosis is a gynecological condition that is closely associated with infertility-from its pathogenesis to treatment modalities, this condition presents a challenge both for patients and clinicians alike when seeking conception, due to low AMH levels, peritoneal inflammation, and the inadvertent removal of healthy ovarian parenchyma at surgery. In fact, around half of endometriosis patients seeking fertility require tertiary-level assisted reproduction techniques to achieve a live birth. Oocyte cryopreservation, a procedure initially designed for oncology patients, has emerged over recent years as a very promising treatment strategy for patients who have been diagnosed with ovarian endometriosis in order to preserve their fertility and obtain a live birth at a later stage in their lives. Counseling patients about oocyte preservation techniques at an early stage in the diagnosis, ideally before the age of 35 and especially prior to any surgical treatment, provides an excellent opportunity to discuss future fertility and the benefits associated with oocyte cryopreservation.

MeSH

Endometriosis, Fertility, Parturition, Ovary, Fertility Preservation, Cryopreservation, Oocytes, Therapeutics, Live Birth

Cited by